Advanced search
Start date
Betweenand


Propolis consumption by asymptomatic HIV-individuals: Better redox state? A prospective, randomized, double-blind, placebo-controlled trial

Full text
Author(s):
Show less -
Tasca, Karen Ingrid ; Conte, Fernanda Lopes ; Correa, Camila Renata ; Santiago, Karina Basso ; Cardoso, Eliza de Oliveira ; Manfio, Vanessa Martinez ; Garcia, Jessica Leite ; Berretta, Andresa Aparecida ; Sartori, Arthur Alves ; Honorio, Mariana da Silva ; Souza, Lenice do Rosario ; Sforcin, Jose Mauricio
Total Authors: 12
Document type: Journal article
Source: BIOMEDICINE & PHARMACOTHERAPY; v. 162, p. 7-pg., 2023-06-01.
Abstract

Propolis is a natural product has many biological properties of clinical interest, such as anti-inflammatory and antioxidant. Considering that people living with HIV/aids (PLWHA) on effective combined antiretroviral therapy (cART) present early aging due to an intense immune activation, inflammation, and redox imbalance, propolis consumption could offer a benefit to such patients. This double-blind longitudinal study evaluated whether Brazilian green propolis pills intake (500 mg/day for three months) would decrease the oxidative stress of virological suppressed HIV-individuals. To compare each group (propolis, n = 20 versus placebo, n = 20) in both moments (M0, before and M1, after the intervention), the following markers were assessed: plasma malon-dialdehyde (MDA), carbonylation, total oxide nitric, total antioxidant capacity (TAP), superoxide dismutase, catalase, and NFkB and NRF2 gene expression. Data were analyzed using Poisson, Gamma distribution and ANOVA followed by Tukey-Kramer. The groups were homogeneous regarding age, gender, time of diagnosis/ treatment, cART scheme, CD4+ T cell count, and no changes were observed in the diet food, or patients' life-styles. A decreased MDA concentration was seen in the propolis group (M0 = 0.24 & PLUSMN; 0.13, M1 = 0.20 & PLUSMN; 0.10 protein nmol/mg; p = 0.005) as well as a slight but non-significant increase of TAP (M0 = 49.07 & PLUSMN; 13.26, M1 = 52.27 & PLUSMN; 14.86%; p = 0.06). One may conclude that propolis promoted a lower lipid peroxidation and improved the antioxidant system, suggesting that its use may be beneficial to PLWHA in an attempt to contain the intense inflammatory and oxidant activity. (AU)

FAPESP's process: 17/14846-0 - Effect of propolis on immunological, inflammatory and oxidative stress biomarkers in people living with HIV/AIDS (PLWHA) following antiretroviral treatment
Grantee:Karen Ingrid Tasca
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 18/04297-1 - Influence of the propolis use on the metabolic profile of HIV-infected individuals treated with antiretroviral therapy
Grantee:Ana Claudia de Moura Moreira Alves
Support Opportunities: Scholarships in Brazil - Scientific Initiation